Media Partner

Information for Media Partners

International Journal of Drug Regulatory Affairs (IJDRA) is a broad-based journal giving leading international coverage of all aspects of Pharmaceutical Sciences. It publishes high quality original research & reviews. By advertising in IJDRA, you can reach the targeted audiences worldwide. Your product information disseminates internationally with comparatively low cost budget.


Regulatory Affairs professionals /Scholars, Patent agents, IPR / F&D / R&D professionals, Pharmacologists; toxicologists; Pharmaceutical researchers; Pharmacists; Clinicians, Analysts, Medical and Health Sciences etc.

Advertisement Policy:

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

This Journal carries an advertisement, which generates income, but journal not be dominated by advertisements, and advertising must not be allowed to influence editorial decisions. Journal follows advertising policies as per International Committee of Medical Journal Editors (ICMJE).

Advertising and Special Services Contact Information:

Dr. Jitendra Badjatya
Phone: +91-7096160846


Company: BlueTech Media

Online Event: 2nd Edition - India Biopharma Leaders Conclave

Date : 26th-27th May

Venue : Hotel Novotel Convention Centre, Hitec City, Hyderabad

Description: Bluetech Media is delighted to invite you to partner with us for the 2nd Edition of India Biopharma Leaders Conclave, scheduled on 26th-27th May 2022, at Hotel Novotel Convention Centre, Hitec City, Hyderabad. The world of the bio Pharma industry moves toward adopting emerging technologies to discover drugs, adapting existing scientific techniques to find new therapeutic approaches within the RNA field, and decentralizing clinical trials.

India Biopharma Leaders Conclave is a phenomenal event that will be bringing together people from different domains of the pharmaceutical and biopharmaceutical world to discuss on the topics related to Biosimilars and Biologics. The event aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars, biologics, biopharmaceuticals and more. This conference will provide all our participants B2B sessions, where they will be able to reach out and make a mark for themselves globally.  

Event website:  :

Register Now :



Company: Virtue Insight

Event: 5th Annual Pharma Regulatory Summit 2022

Venue: 09th & 10th March 2022, Virtual Conference (Time Zone – IST)

Description: Join 5th Annual Pharma Regulatory Summit 2022 to discuss multi-regional cooperation, global harmonization and best practices related to India’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure certainty in India and strategic initiatives to improve collaboration and cooperation.


E-mail - or Call M: +91 9361957193 or +91 44 24762472

  • Early Bird Discount Price (Valid Till 24th January 2022) – (INR 7,000 + GST (18%) per delegate)
  • Standard Price (Valid From 25th January 2022)  - (INR 9,000 + GST (18%) per delegate)

Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to

Event Website:  


Contact: +91 9361957193 / +91 44 24762472


Company: Chandigarh College of Pharma


Venue: Chandigarh College of Pharmacy,Landran, Mohali, SAS Nagar-140307, Punjab


Major challenges to develop a better health care system include globalization, web-based sales and information, broader safety concerns, public health versus pharmaceutical industry economic growth, monitoring of established products, developing and emerging countries, attitudes and perceptions to benefit and harm, outcomes and impact, etc.
Through this conference we aim to bring the world-class leaders in this field at a common platform to connect, learn and network. The conference will bring-forth the participants and the representatives from various fields of pharmacovigilance, drug safety and clinical studies under a common umbrella, and will provide them an opportunity to network with various industry professionals including pharmaceuticals, biologics, devices, CROs and PV service providers. This conference will provide a podium for the participants to discuss, share and stay updated with present state of affairs in pharmacovigilance and drug safety. It will also allow all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field.

Event Website:


Contact: +91-9781925277 / +91-9781925296



Company: Powered By: PRA Consultancy | Organized by: Hubplus Events 

Event: GCC Regulatory Affairs Pharma Summit 2022 

Venue: March 21 & March 22, On-site Summit at Habtoor Grand Resort, Autograph Collection, in Dubai- UAE 


GCC Regulatory Affairs Pharma Summit is an annual event that provides platform for pharmaceutical regulatory experts and industry professionals in the GCC region to share insights and discuss about the latest updates in the pharmaceutical regulations. 

This Summit is one of the first and strategic meeting place in the GCC region for local and international pharmaceutical and medical industry professionals to meet and discuss on topics related to all aspects of regulatory affairs, legal and compliance. 

Over the course of two days, 50+ speakers will analyze and discuss the important factors affecting the pharmaceutical regulatory market. A gathering of 300+ international and local experts and professionals will come together to network and share knowledge on the specifics and initiatives in regulatory affairs in the GCC region. 

Event website: 


Contact: +971 54 306 8878; Madre, Events Manager 


Press release:

GCC Pharma summit brings focus on efficient drug safety and approval protocols

7th GCC Regulatory Affairs Pharma Summit brings together healthcare authorities and pharmaceutical industry to discuss post-pandemic landscape and competitive regulations

Dubai – UAE, 21st & 22nd March 2022: Healthcare regulators in the Gulf region and pharmaceutical industry professionals came together to discuss the increasing importance of expediting approval of new drugs and vaccines in the aftermath of COVID-19, as well as competitive pharmaceutical regulations at the 7th GCC Regulatory Affairs Pharma Summit, held 21-22 March 2022 in Dubai.

The annual summit, which is the region’s foremost platform for local and international pharmaceutical and medical industry professionals to engage with healthcare administrators across GCC, plays a vital role in expediting drug registration and approvals, thereby improving patient access to healthcare.

Along with familiarizing professionals on the current priorities in pharmaceutical regulations across GCC, the Summit also focused on mergers and acquisitions in the in the pharmaceutical sector, in addition to the importance of pharmacovigilance. Pharmacovigilance involves the detection, assessment, understanding and prevention of adverse effects of medicines and vaccines.

Addressing the delegates at the Summit, His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing Sector in the UAE Ministry of Health and Prevention, said: “If I will go to recognize our ecosystem and how it has been supported in the UAE and the Pharma Market Value, and how the pharma companies are being supported in the market; we are able to reach the highest healthcare market value by 2022 which is 81.4 and it is expected to reach 139.9 billion in 2030 billion UAE Dirhams. In addition, the UAE Pharmaceutical market has reached a percentage of 14.4 and is expected to increase to 23.8 billion in 2030.”

H.E Dr. Al Amiri also spoke about the advancing pharmaceutical innovation, by stating that there are 175 new molecular entities registered in the past three years and that this number is the highest number thus far of registered NMEs in MEA.

When H.E spoke about the local manufacturing activities, he stated in his presentation that there are 1800+ Locally manufactured products and 156 innovative medicines produced locally.

The first day of the Summit heard healthcare authorities in the UAE, Oman, and Bahrain providing updates on the pharma regulations in place in their respective domains, and later joining senior executives from leading regional and international pharmaceuticals companies for a round table discussion.

The industry professionals on their part highlighted the most important drug-related issues to be considered by GCC regulatory authorities, such as Value-based Pricing, Lifecycle Management, Combination Products, Biosimilars & Interchangeable Biologics, Value-added Medicine, and Regulatory Timelines. Senior executives representing the health authorities in Jordan, Tunisia, and Ethiopia briefed the delegates at the Summit on the practices and procedures they have adopted for fast and efficient registration and approval of drugs.

“Knowledge and alignment with international practices and standards in healthcare are relevant more than ever today. Consistent focus on maintaining high standards and adopting best international practices played the major role in GCC healthcare coming up with a robust response to COVID-19,” Dr. Najiba Al Shezawy, Managing Director at PRA Consultancy, the organizer of the summit, said referring to the importance of the GCC Regulatory Affairs Pharma Summit,

Procuring vaccines early on and launching extensive vaccination campaigns were instrumental in GCC countries leading in reopening to the world post the pandemic. The UAE led internationally in vaccination and became the first in the Arab world to begin manufacturing of a COVID-19 vaccine. The pandemic is predicted to spur drug manufacturing across the GCC.

“The GCC Pharma Affairs Regulatory Summit has evolved into a premier forum for knowledge exchange within the region’s healthcare.,” added Dr Shezawy.

“A dynamic and progressive regulatory framework that makes patient safety the topmost priority is critical for GCC given the healthcare targets and projected demand for pharmaceuticals across the region. The GCC Regulatory Affairs Pharma Summit is conceived as a forum to sustain stakeholder collaboration in drug registration and approvals, and thereby improved patient access to healthcare,” said Dr Mona Al Moussli, Managing Director at PRA Consultancy.

A report by Fitch Solutions, pharmaceutical spending in GCC is set to reach $25.7billion by 2028 as urbanization, ageing population and chronic lifestyle-related diseases boost demand.

The GCC Regulatory Affairs Pharma Summit also honored the of the GCC Pharma Regulatory Award 2022. Training sessions, intended to provide professionals from the healthcare and pharmaceuticals industries with an understanding of the drug safety protocols in place in various countries in the region, were also held parallelly during the Summit.


About PRA

Professionals Regulatory Affairs (PRA) is a consultancy based in Dubai that advices and helps companies register pharmaceutical, medical devices, cosmetics, personal care, supplements, veterinary, herbal products & toys with authorities in the MENA region. With its extensive expertise, strong network and reliable connections, the firm can also assist in doing the credibility check of distributors and market access of products in the region.

For more info, visit


Phone +971 56 811 6536




Company: World BI

Media Event: 3rd Pharma and Device Packaging & Labeling Forum (29th March, 13: CET)

Venue: Online (Zoom)


Packaging innovation has had to accelerate at a faster rate than perhaps ever before in recent years to optimize drug delivery for pharma, healthcare professionals and patients alike – but it's necessary to keep up with medical advances, stay ahead of the competition and accommodate the unique and differentiated needs of combination products, biologics, vaccines, and other specialty medicines.

We are inviting you to be a part of WORLD BI’s 3rd Pharma & Device Packaging and Labelling Forum to meet with the industry experts and visionaries from around the world to deliberate over the latest innovations & explore the growing opportunities in the Pharma packaging Industry. The forum will deliver senior-level executive insights, unrivaled networking, and knowledge sharing opportunities with high-value actionable content on multiple facets of the industry.

Event Website:


Contact: 00 44 (0) 20 3129 8222




Event: International Conference on Coronavirus disease (Covid-19): Vaccine research and development. PHARMA COLLOQUIUM 2021

Theme : "Raising awareness towards recent advancement in pharmaceutical research"

Venue: September 13-14, 2021, Holiday Inn Toronto International Airport, Toronto, Canada

Description: International Conference on Coronavirus disease (Covid-19): Vaccine research and development (Pharma Colloquium 2021) welcomes you as our guest to the Toronto during September 13-14, 2021Pharma Colloquium 2021 incorporates about each stage of information, advancement, innovation and organizing; and has a target of making a worldwide gathering for academicians, specialists and business experts to discuss the soundest issues related to PharmaBiotech and Health Care.

Event Website:


Contact: +1 647 258 6016